Abstract
The Global Burden of Diseases collaborators reported in 2016 that among the 30 leading causes of death over the last decade, diarrhoeal disease (GE) is the ninth cause of death overall worldwide. The specific causes of GE in adults and the elderly are poorly identified, but severe GE leading to hospitalization and death is more frequently observed in the elderly. Age is thus clearly a very important risk factor. The aetiology of transmission modes as reported by the US surveillance systems shows that around 60% are person-to-person environmental transmissions and only about 30% are food- and water-borne. The most common settings are long-term care facilities, schools, child care facilities and hospitals. The total economic burden of GE is greatest in young children, but the highest cost per illness is observed among older age groups, largely due to productivity losses resulting from acute illness. In the hospital setting, Clostridium difficile is a common cause of antibiotic-associated diarrhoea, and infection may lead to sepsis or even death. The majority of infections with C. difficile occur among persons aged over 65 years and in those in healthcare facilities, such as hospitals and long-term care facilities. Vaccination programmes against GE-causing pathogens need to take into account the fact that some groups have higher risk of infection and clinical complications (elderly, nursing home residents, travellers), while others have higher risk of transmitting infection to other groups (healthcare workers, food handlers) and some can have both (young children, immunocompromised patients). Vaccine development is at different stages for these various infectious agents. The potential population-level effects and the cost-effectiveness of vaccination also warrant further investigation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mortality GBD, Causes of Death C. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459–544.
Lopman BA, Hall AJ, Curns AT, Parashar UD. Increasing rates of gastroenteritis hospital discharges in US adults and the contribution of norovirus, 1996–2007. Clin Infect Dis. 2011;52(4):466–74.
Kirk MD, Hall GV, Becker N. Gastroenteritis in older people living in the community: results of two Australian surveys. Epidemiol Infect. 2012;140(11):2028–36.
Kirk MD, Pires SM, Black RE, Caipo M, Crump JA, Devleesschauwer B, et al. World Health Organization estimates of the global and regional disease burden of 22 foodborne bacterial, protozoal, and viral diseases, 2010: a data synthesis. PLoS Med. 2015;12(12):e1001921.
Gangarosa RE, Glass RI, Lew JF, Boring JR. Hospitalizations involving gastroenteritis in the United States, 1985: the special burden of the disease among the elderly. Am J Epidemiol. 1992;135(3):281–90.
Chen Y, Liu BC, Glass K, Kirk MD. High incidence of hospitalisation due to infectious gastroenteritis in older people associated with poor self-rated health. BMJ Open. 2015;5(12):e010161.
Wikswo ME, Kambhampati A, Shioda K, Walsh KA, Bowen A, Hall AJ, et al. Outbreaks of acute gastroenteritis transmitted by person-to-person contact, environmental contamination, and unknown modes of transmission—United States, 2009–2013. MMWR Surveill Summ. 2015;64(12):1–16.
Bartsch SM, Lopman BA, Ozawa S, Hall AJ, Lee BY. Global economic burden of norovirus gastroenteritis. PLoS One. 2016;11(4):e0151219.
Barret AS, Jourdan-da Silva N, Ambert-Balay K, Delmas G, Bone A, Thiolet JM, et al. Surveillance for outbreaks of gastroenteritis in elderly long-term care facilities in France, November 2010 to May 2012. Euro Surveill. 2014;19(29):20859.
Lausch KR, Westh L, Kristensen LH, Lindberg J, Tarp B, Larsen CS. Rotavirus is frequent among adults hospitalised for acute gastroenteritis. Dan Med J. 2017;64(1):A5312.
Anderson EJ, Shippee DB, Weinrobe MH, Davila MD, Katz BZ, Reddy S, et al. Indirect protection of adults from rotavirus by pediatric rotavirus vaccination. Clin Infect Dis. 2013;56(6):755–60.
Lopman BA, Curns AT, Yen C, Parashar UD. Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J Infect Dis. 2011;204(7):980–6.
National Center for Health Statistics. Rates of Clostridium difficile infection among hospitalized patients aged ≥65 years,* by Age Group—National Hospital Discharge Survey, United States, 1996–2009. MMWR Morb Mortal Wkly Rep. 2011;60(34):1171.
Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL, Donskey CJ. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis. 2007;45(8):992–8.
Arvand M, Moser V, Schwehn C, Bettge-Weller G, Hensgens MP, Kuijper EJ. High prevalence of Clostridium difficile colonization among nursing home residents in Hesse, Germany. PLoS One. 2012;7(1):e30183.
Campbell RR, Beere D, Wilcock GK, Brown EM. Clostridium difficile in acute and long-stay elderly patients. Age Ageing. 1988;17(5):333–6.
Rudensky B, Rosner S, Sonnenblick M, van Dijk Y, Shapira E, Isaacsohn M. The prevalence and nosocomial acquisition of Clostridium difficile in elderly hospitalized patients. Postgrad Med J. 1993;69(807):45–7.
Walker KJ, Gilliland SS, Vance-Bryan K, Moody JA, Larsson AJ, Rotschafer JC, et al. Clostridium difficile colonization in residents of long-term care facilities: prevalence and risk factors. J Am Geriatr Soc. 1993;41(9):940–6.
Rivera EV, Woods S. Prevalence of asymptomatic Clostridium difficile colonization in a nursing home population: a cross-sectional study. J Gend Specif Med. 2003;6(2):27–30.
Ryan J, Murphy C, Twomey C, Paul Ross R, Rea MC, MacSharry J, et al. Asymptomatic carriage of Clostridium difficile in an Irish continuing care institution for the elderly: prevalence and characteristics. Ir J Med Sci. 2010;179(2):245–50.
Fulton JD, Fallon RJ. Is Clostridium difficile endemic in chronic-care facilities? Lancet. 1987;2(8555):393–4.
Simor AE, Yake SL, Tsimidis K. Infection due to Clostridium difficile among elderly residents of a long-term-care facility. Clin Infect Dis. 1993;17(4):672–8.
Davies KA, Longshaw CM, Davis GL, Bouza E, Barbut F, Barna Z, et al. Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect Dis. 2014;14(12):1208–19.
Alicino C, Giacobbe DR, Durando P, Bellina D, DI Bella AM, Paganino C, et al. Increasing incidence of Clostridium difficile infections: results from a 5-year retrospective study in a large teaching hospital in the Italian region with the oldest population. Epidemiol Infect. 2016;144(12):2517–26.
Debbink K, Lindesmith LC, Baric RS. The state of norovirus vaccines. Clin Infect Dis. 2014;58(12):1746–52.
Tan M, Jiang X. Vaccine against norovirus. Hum Vaccin Immunother. 2014;10(6):1449–56.
Yen C, Tate JE, Hyde TB, Cortese MM, Lopman BA, Jiang B, et al. Rotavirus vaccines: current status and future considerations. Hum Vaccin Immunother. 2014;10(6):1436–48.
Soares-Weiser K, Maclehose H, Bergman H, Ben-Aharon I, Nagpal S, Goldberg E, et al. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev. 2012;11:CD008521.
Leuzzi R, Adamo R, Scarselli M. Vaccines against Clostridium difficile. Hum Vaccin Immunother. 2014;10(6):1466–77.
de Bruyn G, Saleh J, Workman D, Pollak R, Elinoff V, Fraser NJ, et al. Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: a randomized phase 2 clinical trial. Vaccine. 2016;34(19):2170–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ansaldi, F. (2019). Gastroenteritis Burden in the Adult Community: Prospects for Vaccines. In: Michel, JP., Maggi, S. (eds) Adult Vaccinations. Practical Issues in Geriatrics. Springer, Cham. https://doi.org/10.1007/978-3-030-05159-4_16
Download citation
DOI: https://doi.org/10.1007/978-3-030-05159-4_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-05158-7
Online ISBN: 978-3-030-05159-4
eBook Packages: MedicineMedicine (R0)